Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve a) the Un-Audited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Ltd has informed BSE that its Board of Directors will meet on Friday, 13th February 2026 at 4:00 p.m. The main item on the agenda is to consider and approve the un-audited financial results for the quarter and nine months ended 31st December 2025, along with the Limited Review Report from auditors. The meeting may also transact any other business as per the circulated agenda. This is a standard regulatory intimation filed under SEBI Listing Regulations, with no financial numbers disclosed yet.
This is a routine compliance filing ahead of the Q3 FY26 earnings release. Investors should watch the actual results on or after 13th February 2026 for any meaningful signals on the company's performance; the filing itself has no direct impact on stock price.